Data Monitoring and Ethics Committee, CMML201 (a phase II study of azacitidine in chronic myelomonocytic leukaemia)

  • Richard Wilson (Member)

Activity: Consultancy typesContribution to the work of national or international committees and working groups

Description

Data Monitoring and Ethics Committee, CMML201 (a phase II study of azacitidine in chronic myelomonocytic leukaemia)
Period20092012
Work forData Monitoring and Ethics Committee of CMML201 trial, United Kingdom